EuroSciCon Conference on

Stem Cell

Theme: Advancing new progression & horizon of Stem Cell research

Event Date & Time

Event Location

Stockholm, Sweden

18 years of lifescience communication

Previous Conference Performers / Professionals From Around The Globe

Conference Speaker


Mossakowski Medical Research Centre

Conference Speaker


Wroclaw Medical University

Conference Speaker


Agricultural University

Conference Speaker

Marina Wiklander


Conference Speaker


Agricultural University Georgia

Conference Speaker


Pulp and Paper Institute of biotechnology

Conference Speaker


Agricultural University

Conference Speaker


Agricultural University Georgia

Conference Speaker


Qatar University

Conference Speaker


University of Strasbourg France

Conference Speaker


University of the Punjab

Conference Speaker


Central Oilworkers Hospital

Tracks & Key Topics

Stem Cell 2019

About Conference

Theme: Advancing new progression & horizon of Stem Cell research

After successful completion of Stem cells 2018, The 2nd Edition of EuroSciCon Conference Stem Cell 2019 is held by EuroSciCon and the conference is scheduled for May 9-10, 2019 in Stockholm, Sweden.  It focuses on the major issues of Stem Cell Biology field includes prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions.

Aim and Objectives:

Stem Cell 2019 Congress aim is to provide the exclusive research topics where all the participants can be up to date with the Latest developments in the Stem Cell Research. Meeting on Stem Cell 2019 extreme Objective is to be the Premier and Exclusive medicinal services gathering in the overall areas. The estimations of Cell and Stem Cell 2019 are Innovation, Quality, Integrity, Knowledge and Patient care.

What’s New?

Stem Cell 2019 includes international attendee workshops, lectures, and symposia, including a designated registration area, a refreshment break, and gala lunch. So come and join the leading expertise people in the field of Cell and Gene therapy and allied professionals from May 9-10, 2019 in Stockholm, Sweden to keep up with the rapidly accelerating pace of change that is already having an impact on the field of Cell and Gene Therapy and will continue to in the future.

Why attend???

With individuals from all around the globe concentrated on finding out about Stem Cell and Regenerative Medicine and its advances; this is your best chance to achieve the biggest collection of members from the Stem Cell and Regenerative Medicine people group. Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations Heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cells research, regenerative medicine can be as Target Audience.

Who Are Attending?


Opportunities for Conference Attendees

For Researchers &Faculty:

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group Registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event 
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor Booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering   
  • Marketing and Networking with clients

Euroscicon organizes Stem Cells Meetings annually across Europe, Austria, Ireland, Germany, France, Liechtenstein, Lithuania, Finland, Luxembourg, Hungary, Italy, Norway, Poland, Denmark, Macedonia, Greece, Portugal, Romania, Czech Republic, Switzerland, United Kingdom, Belgium, Scotland, Latvia, Ukraine, Sweden, Denmark, Spain, Netherlands Russia, Bulgaria, France, with solitary subject of quickening logical revelations. 





Sessions & Tracks

Stem Cells:

Immature microorganisms are undifferentiated cells, which can separate into specific cells and can partition to deliver more undeveloped cells. They are found in multicellular life forms. In warm-blooded animals, there are two wide kinds of undeveloped cells: embryonic immature microorganisms, which are disconnected from the internal cell mass of blastocysts, and grown-up undifferentiated organisms, which are found in different tissues. In grown-up life forms, immature microorganisms and forebear cells go about as a repair framework for the body, recharging grown-up tissues. In a creating incipient organism, immature microorganisms can separate into all the specific cells—ectoderm, endoderm and mesoderm - yet additionally keep up the ordinary turnover of regenerative organs, for example, blood, skin, or intestinal tissues.

  • Craniofacial tissue engineering
  • Breakthrough in cell culture technology for tissue engineering
  • Cell-based tissue engineering and cell signaling
  • In-situ tissue regeneration
  • Adipose-derived stem cells for regenerative medicine
  • Biomaterials design and technology
  • Nanostructures and nanomaterial

Stem Cell Therapy:

Undifferentiated organism treatment is utilized to treat or avert ailments by utilizing undeveloped cells. It has potential in an extensive variety of domains of potential and remedial examination. This treatment is overall used to supplant or repair hurt cells or tissues . It moreover helps in transplanting youthful microorganisms or giving pharmaceuticals that target undifferentiated living beings starting at now in the body. Undeveloped cell treatment is a rising advancement, the recuperation of body part isn't generally another thought.

  • Mesenchymal stem cells therapy
  • Adipose stem cell therapy
  • Stem cell replacement
  • Stem cell clinical management
  • Stem cell therapy for cancer

Stem Cell Transplantation:

A technique for supplanting youthful blood-shaping cells in the bone marrow that have been wrecked by medications, radiation, or illness. Undifferentiated cells are infused into the patient and make solid platelets. A foundational microorganism transplant might be autologous (utilizing a patient's own undifferentiated cells that were spared before treatment), allogeneic (utilizing undeveloped cells gave by somebody who isn't an indistinguishable twin), or syngeneic (utilizing immature microorganisms gave by an indistinguishable twin).

Worldwide undifferentiated organism showcase is ruling the social insurance industry with its solid and financially savvy technique for treatment with less reactions. The current market for line blood therapeutics represents $6.5 billion, which is relied upon to develop at 33.4% CAGR from 2013-2020.

  • Advances in stem cell transplantation
  • Autologous stem cell transplant
  • Cord blood stem cell transplant
  • Embryonic stem cell transplant

Stem Cell Niche:

Specialty here alludes where foundational microorganisms dwell and get enacted to separate and multiply. Specialty Stem Cells show a solid association in keeping dynamic framework (bone marrow specialty) useful. They are the wellspring of discharged or cell surface factor which incorporates individual from Notch, Wnt, Fibroblast development factor (FGR), Transforming Growth Factor (TGF)- beta, Stem Cell Factor (SCF) and Chemokine families-controls immature microorganism reestablishment, upkeep and survival.

  • Bone Marrow niche- Dynamic/Hyperactive
  • Neural niche- Slow Reactive
  • Transforming Growth Factor
  • Single cell Type
  • Blood cell Niche

Tissue Engineering:

Tissue designing is developing as a noteworthy potential option or reciprocal arrangement, whereby tissue and organ disappointment is tended to by embedding common, manufactured, or semisynthetic tissue and organ copies that are completely useful from the begin, or that develop into the required usefulness. Introductory endeavors have concentrated on skin counterparts for treating consumers, yet an expanding number of tissue composes are currently being designed, and additionally, biomaterials and platforms utilized as conveyance frameworks. An assortment of methodologies are utilized to cajole separated or undifferentiated cells, for example, immature microorganisms, into the coveted cell compose. Remarkable outcomes incorporate tissue-designed bone, veins, liver, muscle, and even nerve courses. Because of the restorative and market potential, there is noteworthy scholarly and corporate enthusiasm for this innovation.

  • Histopathology
  • Tissue biomarkers
  • Tissue graft tolerance
  • Photodynamic therapy
  • Tissue mechanics & mechanobiology

Genetically Modified Stem cell Therapy:

It is a procedural method which makes utilization of the hereditary cell in altering foundational microorganisms for treating or forestalling malady. Hereditarily Modified cell treatment for the most part impacts the course of different hereditary illnesses at DNA/RNA level. In Gene Therapy undeveloped cells utilized are all around established which has some unpredictable outcomes for treating numerous maladies and numerous are not reparable.

  • Stem Cell Secretome
  • Tissue Repair
  • Molecular Basis of Epigenetics
  • Organ Synthesis
  • Gene Therapy Stem Cell
  • Cord Blood Stem Cells
  • Genes used to produce iPSCs
  • Clinical Trials

Embryonic Stem Cell:

Embryonic undifferentiated organisms are pluripotent, which means they can develop (i.e. separate) into all subsidiaries of the three essential germ layers: ectoderm, endoderm and mesoderm. At the end of the day, they can form into every one of the in excess of 200 cell sorts of the grown-up body as long as they are determined to do as such. Embryonic immature microorganisms are recognized by two unmistakable properties: their pluripotency, and their capacity to repeat uncertainly. ES cells are pluripotent, that is, they can separate into all subordinates of the three essential germ layers: ectoderm, endoderm, and mesoderm. These incorporate every one of the in excess of 220 cell writes in the grown-up body. Pluripotency recognizes embryonic undifferentiated organisms from grown-up immature microorganisms found in grown-ups; while embryonic foundational microorganisms can create all cell composes in the body, grown-up undeveloped cells are multipotent and can deliver just a set number of cell writes. Furthermore, under characterized conditions, embryonic immature microorganisms are equipped for proliferating themselves inconclusively. This enables embryonic undifferentiated organisms to be utilized as helpful instruments for both research and regenerative pharmaceutical, since they can create boundless quantities of themselves for proceeded with investigate or clinical utilize.

  • Embryonic stem cell
  • Embryonic stem cell research
  • Pro embryonic stem cell research
  • Human embryonic stem cells

Cancer Stem Cell:

Growth Stem Cells are those cells which are uncommon unfading inside a tumor that can both self-reestablish by isolating and offer ascent to numerous new cell writes that constitute the tumor. Malignancy foundational microorganisms are little subpopulation of tumor cells with the capacity of tumorogenecity, dedifferentiation, chemo and radiotherapy obstruction which eventually result in tumor backslide.

  • Cell surface Markers Therapy
  • Potential Surface Biomarkers   
  • Colorectal cancer  
  • Breast Cancer

Nanotechnology in Stem Cells:

Nanotechnology is the branch of innovation that arrangements with little things that are less 100 nm in measure. Here, to handle the situation of immature microorganisms for some biotherapeutic applications we have to work at the size sizes of atoms and procedures that administer undeveloped cells destiny. Nanotechnology and nanoscience offers monstrous advantages to people with powerful amalgamation of nanotechnology and undeveloped cells.

  • Genetic Engineering nanotechnology and robotics
  • Nanotechnology gene therapy
  • Nanotechnology Ethical issues
  • 2D Nanotopography
  • 3D Nanoscaffolds
  • Nanoimprint Lithography

Application of stem cell in Medicine:

Undifferentiated organism treatments convey gigantic potential for treating various human infections. Anyway the interest for contributor's organs exceeds the accessibility by gigantic extents. Another ordinarily confronted test of organ transplants is the occurrence of dismissal because of the beneficiary's insusceptible framework. The utilization of foundational microorganisms for producing tissues and organ unites holds colossal guarantee to satisfy the generally neglected requirement for organ transplants and to enhance the personal satisfaction for many patients.

Foundational microorganism can be coordinated to produce particular cell composes and can be utilized to supplant weak or worsening tissues. The best preferred standpoint of this method is that it beats join to have incongruence. Such tissues are created from the patient's own undifferentiated cells. Consequently, the odds of unite dismissal by the host's resistant framework diminish fundamentally. Immature microorganisms have been utilized in the treatment of spinal string wounds, stroke, consumes, diabetes, cardiovascular illnesses, osteoarthritis, rheumatoid joint pain and so on.

  • Stem Cells in the treatment of Cardiovascular Diseases
  • Stem Cells in Bone Regeneration
  • Stem Cells in the Treatment of Eyesight
  • Stem Cells in the Treatment of Diabetes
  • Stem Cells in the Treatment of Neurodegenerative Disorders
  • Stem Cells in Wound Healing

Stem cell in Drug Development:

Undifferentiated cell treatment has opened another road in the territory of medication disclosure and improvement. Biopharmaceutical organizations have been working in interpreting fundamental utilizations of undifferentiated cell advances in the medication improvement forms in order to diminish the high weakening rate generally arrange sedate applicants, which has been developing at a quick pace in the previous decade. Approach of immature microorganism advances has given new prospects to fabricate imaginative cell models. The always developing systems utilized for detachment of human/creature embryonic foundational microorganisms (ESCs), bone marrow-determined mesenchymal undeveloped cells, umbilical line undifferentiated organisms, grown-up tissue-particular neural immature microorganisms and human instigated pluripotent foundational microorganisms (iPSC) have prompted the headway of various high throughput and combinatorial screening advancements consequently supplementing the part of undifferentiated organism models in sedate disclosure

  • Cancer clinical trails
  • Clinical research and bioethics
  • Drug screening tools
  • Stem cell biology and regenerative medicine
  • Drug safety and regulations

Stem Cells for Organ Repair:

It has been expressed that undifferentiated cells have a capacity to create a substantial number of cells which thusly helps in shaping the devastated tissue or an organ. Conversely, undeveloped cells can likewise be helped in repairingthe harmed organs, in which the instrument does in two unique choices: bolster component and supplant alternative. The help instrument of the undeveloped cell is recovery or the regrowth of the tissue or organ cells keeping away from inconvenient fibrosis. The supplant alternative of the stem cellis to transplant the foundational microorganism.

  • The Seeds of Regeneration
  • Cell transplantation Therapy
  • Stem Cells to Liver Tissues
  • Stem Cell Exosomes
  • Hematopoietic Stem Cell Homing
  • Mesenchymal stem cells: harnessing cell plasticity

Stem Cell Apoptosis and Signal Transduction:

Apoptosis, a molecularly directed type of cell passing, is basic for the typical working and homeostasis of most multicellular creatures. Apoptosis is directed by a portion of a similar flag transduction pathways already embroiled in other physiological cell reactions. Self-recharging and multiplication of immature microorganism populace are controlled by Apoptosis. Apoptosis of undeveloped cells is accepted to be a dynamic procedure which changes in light of natural conditions. Controlling apoptosis is additionally an imperative concentration for investigations of foundational microorganism transplantation. Abusing the full remedial capability of undifferentiated cells will require full translation of the flag transduction torrential slides for expansion, separation, and apoptosis.

  • Ubiquitination Pathways
  • Cell Signaling in Stem Cells
  • Cellular Proliferation and Tumor Growth
  • Cellular Senescence and Pathways in Aging
  • Molecular & Genomics analysis of Cancer
  • Cancer Stem Cells and impaired apoptosis
  • Apoptosis Transcription Factors and Regulators

Tissue Aging:

The immature microorganism hypothesis of maturing proposes that the maturing procedure is the consequence of the powerlessness of different sorts of undifferentiated cells to keep on replenishing the tissues of a living being with useful separated cells equipped for keeping up unique capacity of the tissue. Hostile to Aging is the procedure or strategy that is proposed to anticipate or constrain the way toward getting to be old. Persisting youth may be achieved if maturing could be halted at an energetic age, however it appears to be impossible that the harm to organs, tissues, cells, and particles known as maturing can be ceased totally by supplanting or repairing those harmed organs, tissues, cells and even atoms appears like a superior technique. These procedures can reestablish capacity to old life forms or can even restore. In numerous tissues, there is an age-related diminishing in undeveloped cell helpfulness anyway not a fatigue of Stem Cells. Such revelations have huge result for the foundational microorganism based treatment of the age-related turmoil.

  • Theories Of Ageing
  • Ageing Demographics
  • Genetics Of Ageing and Life Span
  • Reverses ageing process
  • Rejuvenation
  • Ageing Disorders
  • Ageing Technology
  • Clinical Trials Of Ageing

Reprogramming Stem Cells: Computational Biology:

Computational science, a branch of science including the use of PCs and software engineering to the comprehension and displaying of the structures and procedures of life. It involves the utilization of computational techniques for the portrayal and reproduction of organic frameworks, and in addition for the elucidation of trial information, frequently on a vast scale. The fields of foundational microorganism science and regenerative medication investigate are on a very basic level about understanding unique cell procedures, for example, improvement, reinventing, repair, separation and the misfortune, procurement or support of pluripotency. So as to unequivocally decode these procedures at a sub-atomic level, it is basic to distinguish and think about key administrative qualities and transcriptional circuits. Current high-throughput atomic profiling innovations give an intense way to deal with tending to these inquiries as they permit the profiling of a huge number of quality items in a solitary test. While bioinformatics is utilized to translate the data created by such advancements.

  • Bioinformatics Analysis of Stem Cells
  • Computational Tools for Stem Cell Biology
  • Gene expression analysis
  • Computation in Stem Cell and Developmental Biology
  • Computational Evolutionary Biology
  • Cellular Computing And Drug Discovery
  • Bio-Robotics and biosensors
  • Novel Gene Regulatory Networks

Stem cell Biomarkers:

Bio marker is an organic atom found in blood, other body liquids, or tissues that is an indication of a typical or irregular process, or of a condition or infection. A bio marker might be utilized to perceive how well the body reacts to a treatment for an ailment or condition. In disease research and pharmaceutical, bio markers are utilized as a part of three essential ways:

• To help analyze conditions, as on account of distinguishing beginning period malignancies (Diagnostic).

• To gauge how forceful a condition is, as on account of deciding a patient's capacity to toll without treatment (Prognostic).

  • Cancer Stem Cell Biomarkers
  • Trophoblast Stem Cell Biomarkers
  • Cardiac Stem Cell Biomarkers
  • Hematopoietic Stem Cell Biomarkers
  • Skin Stem Cell Markers
  • Retinal Stem Cell Markers

Bioprocessing & Bio Banking:

Bioprocessing is an innovation utilized for exchanging the ebb and flow lab based routine with regards to undeveloped cell tissue culture to the clinical research as therapeutics requires for the utilization of designing standards and practices to accomplish control, robotization, wellbeing, approval and reproducibility of the procedure and the item. Biobanks are the kind of biorepositories which gathers, procedures, stores and circulates biospecimens to help future logical examination. This assumes a vital part in helping the scientists giving the foundation information of the subject.

  • Cell Bioprocessing
  • Cell Isolation & Cultivation
  • Biological specimens
  • Genomic and genetic disorders biobank
  • Whole exon sequencing for rare disease
  • Vitiligo biobank

3D Bioprinting & Biofabrication:

3D printing is a 3-dimentional printing machine which gives the data of a 2D picture as 3D question. The layer of materials to frame a 3D question is controlled by the PC by giving geometry of the protest. 3D Bioprinting helps Tissue Engineering by giving a top to bottom data of the picture and structure examination of the picture, which helps in tackling the basic issues. Biofabrication is alluded to the creation of counterfeit tissues or organs to address wellbeing challengesin prescription. It frequently utilizes the standard of 3D Bioprinting to frame cells, gels and strands into an organ.

  • 3D Printing for Life science
  • Material consideration for 3D Printing in Tissue Engineering
  • Importance of 3D Bio printing
  • Additive Manufacturing and Other Platforms for 3D-Printing
  • 3D-Printing, Biofabrication and Bioprinting using Microfluidics
  • Bioinks
  • Engineered Tissue
  • Innovative Development in 3D-Bioprinting

Alternative Medicine In Stem Cell:

Immature microorganism explore has pulled in an uncommon measure of consideration and desire because of its potential for applications in the treatment of various restorative conditions. These energizing clinical prospects have produced far reaching support from both the general population and private divisions, and various preclinical investigations and thorough clinical preliminaries have just been started. Late years, in any case, have likewise observed disturbing development in the number and assortment of cases of clinical employments of notional 'undeveloped cells' that have not been satisfactorily tried for security as well as viability.

Novel Stem Cell Technologies:

Undeveloped cell Therapeutics is a progressive change in the realm of current drug. Novel undeveloped cell treatment may change current ideal models for treating heart disappointment patients. Clinical preliminary arranging is in progress at MedStar Heart and Vascular Institute to decide if a novel foundational microorganism treatment will enhance heart work for patients with heart disappointment.

Stem cell & Regenerative Medicine Industry:

Patterns and Perspectives on the Evolving International Landscape introduces a thorough investigation of the development and improvement of the foundational microorganism field, with specific spotlight on embryonic stem (ES) cell and actuated pluripotent stem (iPS) cell look into yields.
MarketsandMarkets is a worldwide statistical surveying and counseling organization situated in the U.S. We distribute deliberately examined statistical surveying reports and fill in as a business insight accomplice to Fortune 500 organizations over the world.

  • Trends in the Stem cell& Regenerative Medicine Industry
  • Stem cell& Regenerative Medicine in drug development

Ethical Issues In Stem Cell Research:

Advance in biotechnology has presented a large group of squeezing moral and approach issues relating to undifferentiated cell investigate. Undifferentiated organism explore offers extraordinary guarantee for understanding fundamental instruments of human improvement and separation. The direction of undifferentiated cell explore is an issue that has drawn much remark, feedback and even legal assertion as of late.


Past Conference Report (Stem Cell 2018)

The EuroSciCon Conference on Stem Cell (Stem Cell 2018) hosted by EuroSciCon Ltd took place at  Hyatt Place, Amsterdam Airport, Amsterdam, Netherlands during April 16- 17, 2018. It was organized by EuroSciCon Ltd and generous response was received from the Editorial Board Members of  EuroSciCon Ltd Journals as well as from eminent scientists, talented researchers, and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018 from EuroSciCon Ltd. The two-day program witnessed thought provoking keynote and plenary presentations from experts in the field of Stem Cell research field highlighting the theme, "Frontiers in Stem Cells & turning ideas into reality ".

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Stem Cell Apoptosis And Signal Transduction
  • Cancer Stem Cells
  • Stem Cell Transplantation & Techniques
  • Reprogramming Stem Cells: Computational Biology
  • Stem Cell Banking
  • Stem Cell Biomarkers
  • Epigenetics
  • Plant Stem Cells
  • Veterinary Stem Cell
  • Nanotechnology In Stem Cells
  • Tissue Regeneration & Therapeutics
  • Alternative Medicine In Stem Cell
  • Novel Stem Cell Technologies
  • Stem Cell Product Development & Commercialization
  • Ethical Issues In Stem Cell Research

The highlights of the meeting were form the eminent keynote lectures from

  • Mark Engelman, UK
  • Robert Bowen, USA
  • Olexandr Korchynskyi, Poland
  • Chandan R Bora, Trinidad and Tobago
  • Zeliha Selamoglu, Turkey

Stem Cell 2018 played an important role in promoting multidisciplinary interactions between science and medicine to enhance research in Stem Cells and Biotechnology. The program covered current and emerging research innovations in the field of Stem Cells and Biotechnology.

We would specially thank the Moderator of the Utku AVCITurkey for his contribution to the conference.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Stem Cell 2018 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, EuroSciCon Ltd would like to announce the commencement of " 2nd Edition of EuroSciCon Conference on Stem Cell " during May 9-10, 2019 at Stockholm, Sweden.

Let us meet again @ Stem Cell 2019




Globally Regenerative Medicines market size is predicted to reach USD 30,237 million by 2022. Recently, Regenerative Medicine has emerged with full of promise approaches to treat and cure complex degenerative disorder and to support, restore the function of tissues and cells in other therapies. North America leads the way of a global market in 2015 and it is expected to remain ascendant during 2015-2022. Stem Cells are used to treat cancer and different immune system diseases. And now Stem Cells are suspected for the treatment in Neurodegenerative Diseases, wound healing, spinal cord injury, etc. The worldwide Stem cell & regenerative medicines market is divided according to product type, application, sources, geography and end users. By the product type stem cells market is again divided into human embryonic stem cells, adult stem cells, IPsec’s, etc. Whereas, regenerative medicines have the capability to regenerate, repair & replace tissues of the organ which are affected due to injury, natural aging process, and some diseases. These medicines are able to restore the performance of cells & tissues, therefore, now researchers are focusing on the new technologies which are basically based on biologics, genes, somatic and stem cells as well. The proliferation and differentiation is the major capability of stem cells owing to which they are of importance in this field. Utilization of Nano-materials in immunomodulation, drug delivery, and wound care make the growth the avenues for the regenerative medicines market.             

The regenerative medicine market is broadly divided into three categories namely biologically derived materials, synthetic materials, and genetically engineered materials. The Synthetic materials and biologically derived materials have high demands in the market due to its higher efficiency as compared to other naturally derived materials.

Raw Material Analysis:

For biologically derived materials for regenerative medicines, demand is higher compared to other naturally derived materials due to its efficiency. The procedures say synthetic materials have used hydrogel in tissue engineered scaffolds. This report provides a complete overview of the growth rate of regenerative medicines and stem cells. It is believed that the stem cell market will grow appreciably. Regenerative medicine is a wider field which encompasses the potential to acquire its achievement. Financially, investment in this field is all by grants, private inventors, and publicly traded stocks. Looking ahead, the regenerative medicine and stem cells market is promising for a number of powerful reasons including. 

Stem Cell-A new opportunity in Cosmeceuticals Market:

The market was evaluated at $42.24 billion in 2016 and is expected to reach a value of $68.72 billion by 2022, witnessing a CAGR of 8.52% during the predicted period, 2017-2022.

Cosmeceuticals are the emerging market and so there are lots of opportunities lies in the market that is needed to be explored. North America has been declared as the second largest in the market of cosmeceuticals that has estimated for a share of 31% approx. in 2016.

The United States is the major industry for the organic and in North America natural cosmetic products which shares 85% approx. in 2016 with a market value of $10.62 billion. Whereas, the Asia Pacific is the third largest industry for skin care products market which estimated a share of 22% approx. in 2016.

Global Market Study of Stem Cells & Regenerative Medicine:

USA: The regenerative medicine & stem cell market is assuming to reach $38.70 billion by the year 2022 from $ 13.33 billion in 2016 at a CAGR of 23.56%.

Europe: The regenerative medicine & stem cells market is expected to reach USD 13.578 billion by 2022 from USD 5.06 billion in 2016 at a CAGR of 21.80% during the period 2016-2022.

Middle East: The regenerative medicines market is expected $ 40.55 billion revenue in 2022 from $ 17.03 billion revenue in 2016.



Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!